These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19220822)
1. Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. van Hal SJ; Marriott DJ; Chen SC; Nguyen Q; Sorrell TC; Ellis DH; Slavin MA; Transpl Infect Dis; 2009 Apr; 11(2):122-7. PubMed ID: 19220822 [TBL] [Abstract][Full Text] [Related]
2. Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome. Fernández-Ruiz M; Cardozo C; Salavert M; Aguilar-Guisado M; Escolà-Vergé L; Muñoz P; Gioia F; Montejo M; Merino P; Cuervo G; García-Vidal C; Aguado JM; ; Transpl Infect Dis; 2019 Dec; 21(6):e13195. PubMed ID: 31610077 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981 [TBL] [Abstract][Full Text] [Related]
4. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [TBL] [Abstract][Full Text] [Related]
5. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Swoboda SM; Merz WG; Lipsetta PA Surg Infect (Larchmt); 2003; 4(4):345-54. PubMed ID: 15012861 [TBL] [Abstract][Full Text] [Related]
6. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O; Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476 [TBL] [Abstract][Full Text] [Related]
8. [Role of anidulafungin in solid organ transplant recipients]. Aguado JM; Ayats J Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432 [TBL] [Abstract][Full Text] [Related]
9. Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona. Al-Obaidi MM; Marquez J; Afghan A; Zangeneh TT Mycoses; 2023 Mar; 66(3):237-241. PubMed ID: 36401812 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Candidemia in Solid-Organ Transplant Recipients. Sari N; Yanik Yalçin T; Erol Ç; Kurt Azap Ö; Arslan H; Karakaya E; Sezgin A; Haberal M Exp Clin Transplant; 2024 Jan; 22(Suppl 1):160-166. PubMed ID: 38385390 [TBL] [Abstract][Full Text] [Related]
11. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Aslam S; Rotstein C; Clin Transplant; 2019 Sep; 33(9):e13623. PubMed ID: 31155770 [TBL] [Abstract][Full Text] [Related]
12. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Viudes A; Pemán J; Cantón E; Ubeda P; López-Ribot JL; Gobernado M Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):767-74. PubMed ID: 12461585 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112 [TBL] [Abstract][Full Text] [Related]
15. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Baran J; Muckatira B; Khatib R Scand J Infect Dis; 2001; 33(2):137-9. PubMed ID: 11233850 [TBL] [Abstract][Full Text] [Related]
16. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital. Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Neu N; Malik M; Lunding A; Whittier S; Alba L; Kubin C; Saiman L Pediatr Infect Dis J; 2009 Sep; 28(9):806-9. PubMed ID: 19636286 [TBL] [Abstract][Full Text] [Related]
18. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation. Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451 [TBL] [Abstract][Full Text] [Related]
19. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056 [TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infections in solid organ transplant recipients. Shoham S; Marr KA Future Microbiol; 2012 May; 7(5):639-55. PubMed ID: 22568718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]